...BRCA2 mutations, and also due to new staging standards and use of nuclear magnetic resonance. This increase in the indic...
...BRCA2) can be involved in pathogenesis of hereditary breast cancer which can be explained by incomplete penetrance of BR...
...BRCA2. We studied the clinical activity and toxicity of veliparib in ovarian cancer patients carrying a germline BRCA1 o...
...BRCA2 negative familial breast cancer (BRCAx) to BRCA1-positive, BRCA2-positive and sporadic cases without a family hist...
...BRCA2 show de novo loss of CHD4 expression in vitro. Moreover, BRCA2 mutant ovarian cancers with reduced CHD4 expression...
...BRCA2 cohorts showed a 47% (P = .002) increase in cholesterol level in the BRCA2 cohort when compared with diallylic lip...
...BRCA2 associated with breast cancer have been reported in different populations. However, the common BRCA1 and BRCA2 mut...
Almost exactly 20 years after their discovery, the BRCA1 and BRCA2 genes have become the target of the first "personaliz...
...BRCA2 or PALB2) and a mutational signature of DNA damage repair deficiency. Of 8 patients who received platinum therapy,...
...BRCA2 (BRCA) mutations among 190 women with triple-negative breast cancer, unselected for family history, diagnosed at a...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
